نتایج جستجو برای: 5 fluorouracil colon cancer

تعداد نتایج: 2083830  

Two common single nucleotide polymorphisms (SNPs) of the human TLR4 gene, namely Asp299Gly (D299G) and Thr399Ile (T399I), have been shown to impair the ability of certain individuals to respond properly to TLR4 ligands. 5-Fluorouracil (5-FU) is widely used for the treatment of patients with advanced colon cancers. The present study examined the impact of two common polymorphisms of the TLR4 gen...

Journal: :Cancer research 2011
Thierry Voisin Aadil El Firar Magali Fasseu Christiane Rouyer-Fessard Véronique Descatoire Francine Walker Valérie Paradis Pierre Bedossa Dominique Henin Thérèse Lehy Marc Laburthe

Resistance to apoptosis is a recurrent theme in colon cancer. We have shown previously that the 7-transmembrane spanning receptor OX1R for orexins promotes robust apoptosis in the human colon cancer cell line HT29 through an entirely novel mechanism involving phosphorylation of tyrosine-based motifs in OX1R. Here, we investigated the status of OX1R in a large series of human colorectal tumors a...

2012
Yoo Sung Lee Hee Cheol Kim Kyung Ook Jung Yong Beom Cho Seong Hyeon Yun Woo Yong Lee Ho-Kyung Chun

PURPOSE Adjuvant chemotherapy is currently recommended for Stage IIIA colon cancers. This study aimed to elucidate the oncologic outcomes of Stage IIIA colon cancer according to the chemotherapeutic regimen based on a retrospective review. METHODS From 1995 to 2008, Stage IIIA colon cancer patients were identified from a prospectively maintained database at a single institution. Exclusion cri...

2017
Sang Hee Cho Chang Soo Hong Hee Nam Kim Min Ho Shin Ka Rham Kim Hyun Jeong Shim Jun Eul Hwang Woo Kyun Bae Ik Joo Chung

PURPOSE Fibroblast growth factor receptor 4 (FGFR4) plays an important role in cancer progression during tumor proliferation, invasion, and metastasis. This study evaluated the prognostic role of FGFR4 polymorphism in patients with resected colon cancer, including the underlying mechanism. MATERIALS AND METHODS FGFR4 polymorphism was characterized in patientswho received curative resection fo...

2013
Katsuji Sawai Takanori Goi Kenji Koneri Kanji Katayama Akio Yamaguchi

We report here a case of partial response to hepatic arterial infusion chemotherapy in a patient who developed serious hepatic failure due to unresectable colorectal cancer and hepatic metastasis and showed resistance to systemic chemotherapy with molecular targeted drugs, mFOLFOX6, and FOLFIRI. The patient was a 60-year-old woman who underwent sigmoidectomy for sigmoid colon cancer, lateral po...

Two common single nucleotide polymorphisms (SNPs) of the human TLR4 gene, namely Asp299Gly (D299G) and Thr399Ile (T399I), have been shown to impair the ability of certain individuals to respond properly to TLR4 ligands. 5-Fluorouracil (5-FU) is widely used for the treatment of patients with advanced colon cancers. The present study examined the impact of two common polymorphisms of the TLR4 gen...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Aziz Zaanan Jean-François Fléjou Jean-François Emile Guetz Gaëtan Des Peggy Cuilliere-Dartigues David Malka Cédric Lecaille Pierre Validire Christophe Louvet Philippe Rougier Aimery de Gramont Franck Bonnetain Françoise Praz Julien Taïeb

PURPOSE Adding oxaliplatin to adjuvant 5-fluorouracil (5-FU) chemotherapy improves 3-year disease-free survival (DFS) after resection of stage III colon cancer. Several studies suggest that patients with tumors exhibiting defective mismatch repair (MMR) do not benefit from adjuvant 5-FU chemotherapy, but there are few data on 5-FU-oxaliplatin (FOLFOX) adjuvant chemotherapy in this setting. The ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید